小方制药
(603207)
| 流通市值：8.18亿 | | | 总市值：33.38亿 |
| 流通股本：3919.78万 | | | 总股本：1.60亿 |
| 报告期 | 2024-06-30 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 261,788,742.56 | 471,871,615.15 | 259,984,044.71 | 456,889,741.31 |
| 营业收入 | 261,788,742.56 | 471,871,615.15 | 259,984,044.71 | 456,889,741.31 |
| 二、营业总成本 | 122,116,783.78 | 240,789,017.91 | 123,961,176.43 | 258,636,840.55 |
| 营业成本 | 87,539,532.01 | 162,970,922.24 | 90,458,389.78 | 187,156,839.67 |
| 税金及附加 | 2,081,413.52 | 3,534,365.63 | 1,985,112.7 | 3,995,687.18 |
| 销售费用 | 20,471,502.44 | 44,501,146.63 | 19,546,676.58 | 41,013,645.44 |
| 管理费用 | 7,162,358 | 14,971,263.37 | 6,935,660.5 | 13,632,124.02 |
| 研发费用 | 6,561,697.12 | 16,281,098.95 | 5,236,915.31 | 13,588,548.56 |
| 财务费用 | -1,699,719.31 | -1,469,778.91 | -201,578.44 | -750,004.32 |
| 其中:利息费用 | 16,339.85 | 46,927.45 | 25,801.76 | 65,461.61 |
| 其中:利息收入 | -1,738,004.05 | -1,563,817.93 | -252,462.71 | -856,787.85 |
| 加:公允价值变动收益 | 15,584.9 | 55,137.4 | 27,402.66 | 14,668.99 |
| 加:投资收益 | - | 2,197,701.9 | 1,409,020.57 | 2,955,879.09 |
| 资产处置收益 | - | - | - | 2,691.27 |
| 资产减值损失(新) | 37,154.74 | -97,611.58 | -271,382.81 | -287,305.02 |
| 信用减值损失(新) | -1,694,477.03 | -170,945.25 | -2,012,022.43 | -1,368,923.37 |
| 其他收益 | 1,213,222.86 | 3,113,034.79 | 1,965,801.13 | 6,785,446.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 139,243,444.25 | 236,179,914.5 | 137,141,687.4 | 206,355,357.82 |
| 加:营业外收入 | - | 1,000,037.56 | 1,000,029.82 | 25,573.95 |
| 减:营业外支出 | 310,054.1 | 10,000 | 10,000 | 318,981.92 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 138,933,390.15 | 237,169,952.06 | 138,131,717.22 | 206,061,949.85 |
| 减:所得税费用 | 20,117,459.32 | 33,542,924.4 | 20,165,175.21 | 30,882,023.25 |
| 六、净利润 | 118,815,930.83 | 203,627,027.66 | 117,966,542.01 | 175,179,926.6 |
| 持续经营净利润 | 118,815,930.83 | 203,627,027.66 | 117,966,542.01 | 175,179,926.6 |
| 归属于母公司股东的净利润 | 118,815,930.83 | 203,627,027.66 | 117,966,542.01 | 175,179,926.6 |
| (一)基本每股收益 | 0.99 | 1.7 | 0.98 | 1.46 |
| (二)稀释每股收益 | 0.99 | 1.7 | 0.98 | 1.46 |
| 九、综合收益总额 | 118,815,930.83 | 203,627,027.66 | 117,966,542.01 | 175,179,926.6 |
| 归属于母公司股东的综合收益总额 | 118,815,930.83 | 203,627,027.66 | 117,966,542.01 | 175,179,926.6 |
| 公告日期 | 2024-08-07 | 2024-08-07 | 2024-08-07 | 2023-07-06 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |